Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.53%12.21M | -27.93%41.32M | -13.93%10.18M | -39.03%11.13M | -18.42%16.15M | -30.02%11.15M | 52.62%57.34M | 18.69%11.83M | 88.85%18.25M | 94.27%19.8M |
| Cost of revenue | -45.03%4.91M | -45.76%23.6M | -59.30%5.65M | -48.02%6.01M | -47.26%7.66M | -0.90%8.94M | 37.29%43.52M | 50.33%13.89M | 53.85%11.56M | 71.13%14.53M |
| Gross profit | 230.09%7.3M | 28.22%17.72M | 319.91%4.53M | -23.49%5.12M | 61.15%8.49M | -68.02%2.21M | 135.29%13.82M | -383.12%-2.06M | 211.01%6.69M | 209.82%5.27M |
| Operating expense | -33.12%3.35M | -7.60%14.09M | 58.28%8.14M | 1,353.12%4.22M | -2.69%5.02M | -0.97%5M | -47.20%15.25M | -73.11%5.14M | -109.91%-337K | 68.89%5.16M |
| Selling and administrative expenses | ---- | -7.60%14.09M | ---- | ---- | ---- | ---- | 16.79%15.25M | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | --0 | ---- | ---- | ---- | ---- | -99.37%2.7K | ---- | ---- | ---- |
| -General and administrative expense | ---- | -7.59%14.09M | ---- | ---- | ---- | ---- | 20.74%15.25M | ---- | ---- | ---- |
| Other operating expenses | -33.12%3.35M | 14.92%23.17M | 58.28%8.14M | 4.14%5M | -2.69%5.02M | -0.97%5M | -10.33%20.16M | -59.56%5.14M | 41.25%4.8M | 68.89%5.16M |
| Total other operating income | ---- | ---- | ---- | -84.83%780K | ---- | ---- | 120.48%14.67M | --437.4K | --5.14M | ---- |
| Operating profit | 241.39%3.95M | 354.13%3.63M | 49.88%-3.61M | -87.23%898K | 3,230.77%3.46M | -250.32%-2.79M | 93.79%-1.43M | 60.85%-7.2M | 662.85%7.03M | 107.66%104K |
| Net non-operating interest income (expenses) | 32.29%-65K | 43.22%-221.91K | 0.00%-92K | -16.67%-119K | -11.00%-111K | 11.93%-96K | 8.16%-390.84K | 30.60%-92K | -6.25%-102K | 2.91%-100K |
| Non-operating interest expense | -32.29%65K | -43.22%221.91K | 0.00%92K | 16.67%119K | 11.00%111K | -11.93%96K | -8.16%390.84K | -30.60%92K | 6.25%102K | -2.91%100K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 11.98%12.87M | 469.37%11.49M | ||||||||
| Less:Write off | ---- | -11.98%-12.87M | ---- | ---- | ---- | ---- | -469.37%-11.49M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 167.54%3.56M | 505.88%14.42M | 2,703.42%12.28M | 102.67%18.04M | 589.64%1.33M | 2.38M | 438K | 1,981.38%5.14M | 2,572.97%8.9M | |
| Income before tax | 577.86%7.45M | 154.75%30.69M | 225.15%8.58M | -88.76%779K | 140.24%21.39M | -180.23%-1.56M | 145.39%12.05M | 69.98%-6.85M | 730.97%6.93M | 890.15%8.91M |
| Income tax | 291.33%1.53M | 98.64%2.43M | 253.85%322K | 72.70%620K | 196.83%1.03M | 26.05%392K | 34.36%1.22M | 137.13%91K | 312.64%359K | -15.37%347K |
| Net income | 403.13%5.91M | 164.54%23.45M | 218.88%8.26M | -97.58%159K | 137.94%20.36M | -219.56%-1.95M | 132.29%8.87M | 69.25%-6.95M | 654.35%6.57M | 656.80%8.56M |
| Net income continuous operations | 403.13%5.91M | 162.64%25.86M | 218.88%8.26M | -97.58%159K | 137.94%20.36M | -219.56%-1.95M | 135.86%9.85M | 69.25%-6.95M | 654.35%6.57M | 656.80%8.56M |
| Net income discontinuous operations | ---- | -145.43%-2.41M | ---- | ---- | ---- | ---- | ---980.76K | ---- | ---- | ---- |
| Noncontrolling interests | 94.89%-24K | -10,303.39%-64.5K | 99.60%-2K | 0 | 473.39%407K | -196.11%-470K | 99.93%-620 | -87.77%-503K | 147.37%117K | 65.06%-109K |
| Net income attributable to the company | 501.01%5.94M | 163.27%25.93M | 228.19%8.26M | -97.54%159K | 130.25%19.96M | -229.60%-1.48M | 136.98%9.85M | 71.14%-6.44M | 787.85%6.45M | 807.51%8.67M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 501.01%5.94M | 163.27%25.93M | 228.19%8.26M | -97.54%159K | 130.25%19.96M | -229.60%-1.48M | 136.98%9.85M | 71.14%-6.44M | 787.85%6.45M | 807.51%8.67M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 490.91%0.0043 | 164.79%0.0188 | 227.66%0.006 | -97.87%0.0001 | 128.57%0.0144 | -237.50%-0.0011 | 136.79%0.0071 | 70.99%-0.0047 | 771.43%0.0047 | 800.00%0.0063 |
| Diluted earnings per share | 490.91%0.0043 | 164.79%0.0188 | 227.66%0.006 | -97.87%0.0001 | 128.57%0.0144 | -237.50%-0.0011 | 136.79%0.0071 | 70.99%-0.0047 | 771.43%0.0047 | 800.00%0.0063 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.